참고문헌
- Al-Tawfiq, J. 2008. Therapeutic options for human brucellosis. Expert Rev. Anti. Infect. Ther. 6: 109-120. https://doi.org/10.1586/14787210.6.1.109
- Al Dahouk, S., R. Hagen, K. Nockler, H. Tomaso, M. Wittig, H. Scholz, et al. 2005. Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. Chemotherapy 51: 352-356. https://doi.org/10.1159/000088960
- Almuneef, M., Z. Memish, M. Al-Shaalan, E. Al-Banyan, S. Al-Alola, and H. Balkh. 2003. Brucella melitensis bacteremia in children: Review of 62 cases. J. Chemother. 15: 76-80. https://doi.org/10.1179/joc.2003.15.1.76
- Ariza, J., M. Bosilkovski, A. Cascio, J. D. Colmenero, M. J. Corbel, M. E. Falagas, et al. 2007. Perspectives for the treatment of brucellosis in the 21st century: The Ioannina recommendations. PLoS Med. 4: 1872-1878
- Baykam, N., H. Esener, O. Ergonul, S. Eren, A. K. Celikbas, and B. Dokuzo guz. 2004. In vitro antimicrobial susceptibility of Brucella species. Int. J. Antimicrob. Agents 23: 405-407. https://doi.org/10.1016/j.ijantimicag.2003.09.024
- Bodur, H., N. Balaban, S. Aksaray, V. Yetener, E. Akinci, A. Colpan, and A. Erbay. 2003. Biotypes and antimicrobial susceptibilities of Brucella isolates. Scand. J. Infect. Dis. 35: 337-338. https://doi.org/10.1080/00365540310008348
- Boschiroli, M., V. Foulongne, and D. O'Callaghan. 2001. Brucellosis: A worldwide zoonosis. Curr. Opin. Microbiol. 4: 58-64. https://doi.org/10.1016/S1369-5274(00)00165-X
- Bricker, B. and S. Halling. 1995. Enhancement of the Brucella AMOS PCR assay for differentiation of Brucella abortus vaccine strains S19 and RB51. J. Clin. Microbiol. 33: 1640-1642.
- CLSI. 2010. Performance standards for antimicrobial susceptibility testing. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
- Dorsch, M., E. Moreno, and E. Stackebrandt. 1989. Nucleotide sequence of the 16S rRNA from Brucella abortus. Nucleic. Acids. Res. 17: 1765. https://doi.org/10.1093/nar/17.4.1765
- Ewalt, D. and B. Bricker. 2000. Validation of the abbreviated Brucella AMOS PCR as a rapid screening method for differentiation of Brucella abortus field strain isolates and the vaccine strains, 19 and RB51. J. Clin. Microbiol. 38: 3085-3086.
- Garcia-Rodriguez, J., J. Garcia Sanchez, and I. Trujillano. 1991. Lack of effective bactericidal activity of new quinolones against brucella spp. Antimicrob. Agents chemother. 35: 756-759. https://doi.org/10.1128/AAC.35.4.756
- Gargani, G. and A. Pacetti. 1986. Sensitivity of 115 strains of the genus Brucella to some antibiotics (cephalosporins, ureidopenicillins and aminoglycosides). Chemioterapia. 5: 7-13.
- Hall, W. and R. Manion. 1970. In vitro susceptibility of Brucella to various antibiotics. Appl. Environ. Microb. 20: 600-604.
- Hall, W. 1990. Modern chemotherapy for brucellosis in humans. Rev. Infect. Dis. 12: 1060-1099. https://doi.org/10.1093/clinids/12.6.1060
- Kim, S. G., Y. H. Kim, M. H. Cho, Y. J. Lee, and C. K. Park. 2009. Biochemical characteristics of Brucella abortus isolated from cattle in Gyungbuk Province. Korean J. Vet. Serv. 32: 139-146.
- Lopez-Merino, A., A. Contreras-Rodriguez, R. Migranas-Ortiz, R. Orrantia-Gradin, G. Hernandez-Oliva, A. Gutierrez-Rubio, and O. Cardenosa. 2004. Susceptibility of Mexican Brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis. Scand. J. Infect. Dis. 36: 636-638. https://doi.org/10.1080/00365540410020767
- Mantur, B. G., S. K. Amamath, and R. S. Shinde. 2007. Review of clinical and laboratory features of human brucellosis. Indian J. Med. Microbiol. 25: 188-202. https://doi.org/10.4103/0255-0857.34758
- Marianelli, C., C. Graziani, C. Santagelo, M. T. Xibilia, A. Imbriani, A. Amato, et al. 2007. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy. J. Clin. Microbiol. 45: 2923-2928. https://doi.org/10.1128/JCM.00822-07
- Marianelli, C., F. Ciuchini, M. Tarantino, P. Pasquali, and R. Adone. 2004. Genetic bases of the rifampin resistance phenotype in Brucella spp. J. Clin. Microbiol. 42: 5439-5443. https://doi.org/10.1128/JCM.42.12.5439-5443.2004
- Maves, R. C., R. Castillo, A. Guillen, B. Espinosa, R. Meza, N. Espinoza, et al. 2011. Antimicrobial susceptibility of Brucella melitensis isolates in Peru. Antimicrob. Agents Chemother. 55: 1279-1281. https://doi.org/10.1128/AAC.00979-10
- Mortensen, J., D. Moore, J. Clarridge, and E. Young. 1986. Antimicrobial susceptibility of clinical isolates of Brucella. Diagn. Micro. Infect. Dis. 5: 163-169. https://doi.org/10.1016/0732-8893(86)90118-5
- Nielsen, K. and J. R. Duncan. 1990. Animal brucellosis. 1st Ed. CRC press.
- Park, M. S., Y. S. Woo, M. J. Lee, S. K. Shim, H. K. Lee, Y. S. Choi, et al. 2003. The First Case of Human Brucellosis in Korea. Infect. Chemother. 35: 461-466.
- Park, M. Y., C. S. Lee, Y. S. Choi, S. J. Park, J. S. Lee, and H. B. Lee. 2005. A sporadic outbreak of human brucellosis in Korea. J. Korean Med. Sci. 20: 941-946. https://doi.org/10.3346/jkms.2005.20.6.941
- Rolain, J., M. Maurin, and D. Raoult. 2000. Bactericidal effect of antibiotics on Bartonella and Brucella spp.: Clinical implications. J. Antimicrob. Chemoth. 46: 811-814. https://doi.org/10.1093/jac/46.5.811
- Romero, C., C. Gamazo, M. Pardo, and I. Lopez-Goni. 1995. Specific detection of Brucella DNA by PCR. J. Clin. Microbiol. 33: 615-617.
- Shaalan, M., Z. Memish, S. Mahmoud, A. Alomari, M. Khan, M. Almuneef, and S. Alalola. 2002. Brucellosis in children: clinical observations in 115 cases. Int. J. Infect. Dis. 6: 182-186. https://doi.org/10.1016/S1201-9712(02)90108-6
- Solera, J., A. Espinosa, E. Martinez-Alfaro, L. Sanchez, P. Geijo, E. Navarro, et al. 1997. Treatment of human brucellosis with doxycycline and gentamicin. Antimicrob. Agents Chemother. 41: 80-84.
- Wee, S. H., H. M. Nam, and C. H. Kim. 2008. Emergence of brucellosis in cattle in the Republic of Korea. Vet. Rec. 162: 556-557. https://doi.org/10.1136/vr.162.17.556
- WHO. 1986: Joint FAO/WHO Expert Committee on Brucellosis: Sixth report. World Health Organization.
피인용 문헌
- In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey vol.47, pp.6, 2012, https://doi.org/10.3109/00365548.2014.988748
- Antimicrobial Resistance in Leptospira , Brucella , and Other Rarely Investigated Veterinary and Zoonotic Pathogens vol.6, pp.4, 2018, https://doi.org/10.1128/microbiolspec.arba-0029-2017
- Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In vol.21, pp.8, 2012, https://doi.org/10.1208/s12249-020-01833-7
- Cell membrane components of Brucella melitensis play important roles in the resistance of low-level rifampicin vol.14, pp.12, 2020, https://doi.org/10.1371/journal.pntd.0008888